Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
NCT05526079 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2024-01-29
Summary
The purpose of this project is to determine if in a selected group of patients, at higher risk of wound dehiscence and other complications, treatment by local excision and management by a "watchful waiting" or an initial "non-operative management" approach, with an offer of radical resection only to those patients whose tumors demonstrate "regrowth" will maintain acceptable local control and overall survival rate for the whole cohort.
Conditions
Interventions
- OTHER
-
Watchfuf waiting
Careful review of patient response with the hope of avoiding radical surgery.
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Principal Investigators
-
Amr Aref, MD · Ascension St. John Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-10
- Primary Completion
- 2028-07-09
- Completion
- 2029-07-09
Countries
- United States
Study Locations
More Related Trials
-
Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer
NCT04405206 ·Status: UNKNOWN
-
Study for Wait and Watch Suitable in Rectal Cancer
NCT06252142 ·Status: RECRUITING
-
Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy
NCT02052921 ·Status: TERMINATED ·Phase: NA
-
Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response
NCT03846726 ·Status: COMPLETED
-
Non-Operative Management and Early Response Assessment in Rectal Cancer
NCT03904043 ·Status: COMPLETED ·Phase: NA
-
Watch and Wait as Treatment for Patients With Rectal Cancer
NCT03125343 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer
NCT01211210 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer
NCT02710812 ·Status: UNKNOWN
-
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
NCT05629442 ·Status: NOT_YET_RECRUITING
-
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT04443543 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.
NCT01941979 ·Status: UNKNOWN ·Phase: PHASE3
-
Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
NCT04095299 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer
NCT01716949 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer
NCT01613469 ·Status: TERMINATED ·Phase: PHASE2
-
"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer
NCT03426397 ·Status: RECRUITING
-
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
NCT03594630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission
NCT05964530 ·Status: RECRUITING ·Phase: NA
-
Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
NCT01671891 ·Status: UNKNOWN
-
Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
NCT05772923 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
NCT04215731 ·Status: RECRUITING ·Phase: PHASE3
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
NCT05969938 ·Status: UNKNOWN
-
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2